| Literature DB >> 34094099 |
Qi-Long Hu1, Ke-Qiang Hou1, Jian Li1, Yang Ge1, Zhen-Dong Song1, Albert S C Chan1, Xiao-Feng Xiong1.
Abstract
Chemical modification of a specific amino acid residue on peptides represents an efficient strategy to improve their pharmacokinetics and facilitates the potential to achieve post-synthetic diversification of peptides. Herein, we reported the first Pd-catalyzed late-stage ortho-olefination of Tyr residues on peptides with high chemo- and site-selectivity, by employing the easily attached and removable silanol as a bifunctional protecting group and directing group. Up to hexapeptides with variation on amino acid sequences or locations of the Tyr residue and different olefins were compatible with this protocol, which enriched the chemical toolbox for late-stage modification via C(sp2)-H functionalization. Furthermore, the orthogonal protection strategies of Tyr were also developed and could be applied to SPPS. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 34094099 PMCID: PMC8159358 DOI: 10.1039/d0sc02439b
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Fig. 1(a). Previous work about modification of tyrosine residues. (b). Traditional strategy for late-stage modification and our strategy.
Optimization of the reaction conditionsa
|
| |||||
|---|---|---|---|---|---|
| Entry | Base | Oxidant | Solvent | Additive | Yield |
| 1 | Li2CO3 | AgOAc | DCE | L1 | n.d |
| 2 | KHCO3 | O2 |
| — | n.d |
| 3 | Li2CO3 | AgOAc | DCE | — | n.d |
| 4 | — | Ag2CO3 | HFIP | L2 | n.d |
| 5 | Li2CO3 | Ag2CO3 | DCE | — | 12 |
| 6 | Li2CO3 | PhI(OAc)2 | DCE | — | 47 |
| 7 | NaHCO3 | PhI(OAc)2 | DCE | — | 22 |
| 8 | LiOAc | PhI(OAc)2 | DCE | — | <10 |
| 9 | LiH2PO4 | PhI(OAc)2 | DCE | — | 38 |
| 10 | Li3PO4 | PhI(OAc)2 | DCE | — | 58 |
| 11 | Li3PO4 | PhI(OAc)2 | DCE | L1 | 51 |
| 12 | Li3PO4 | PhI(OAc)2 | DCE | BQ | 76(73 |
Reaction conditions: 1a (0.1 mmol, 1.0 eq.), 2a (0.4 mmol, 4.0 eq.), Pd(OAc)2 (0.01 mmol, 0.1 eq.), additive (0.02 mmol, 0.2 eq.), oxidant (0.3 mmol, 3.0 eq.), and base (0.2 mmol, 2.0 eq.) in solvent (1.0 mL) at 90 °C for 24 h.
1H NMR yield using 1,3,5-trimethoxybenzene as the internal standard.
L1 = (+)-menthyl(O2C)-Leu-OH.
t-AmOH = tertiary amyl alcohol.
L2 = Ac-Gly-OH.
Benzoquinone.
Isolated yield.
Scheme 1Scope of coupling partners and orthogonal protection strategies. Reaction conditions: 1a (0.2 mmol, 1.0 eq.), 2 (0.8 mmol, 4.0 eq.), Pd(OAc)2 (0.02 mmol, 0.1eq.), BQ (0.04 mmol, 0.2 eq.), PhI(OAc)2 (0.6 mmol, 3.0 eq.), and Li3PO4 (0.4 mmol, 2.0 eq.) in DCE (2.0 mL) at 90 °C for 24 h.
Scheme 2Scope of dipeptide substrates.aReaction conditions: 4 (0.2 mmol, 1.0 eq.), 2a (0.8 mmol, 4.0 eq.), Pd(OAc)2 (0.02 mmol, 0.1 eq.), BQ (0.04 mmol, 0.2 eq.), PhI(OAc)2 (0.6 mmol, 3.0 eq.), and Li3PO4 (0.4 mmol, 2.0 eq.) in DCE (2.0 mL) at 90 °C for 24 h.
Scheme 3Application and late-stage peptide modification.For peptide synthesis, see the ESI.† Reaction conditions: 6 (0.2 mmol, 1.0 eq.), 2a (0.8 mmol, 4.0 eq.), Pd(OAc)2 (0.02 mmol, 0.1 eq.), BQ (0.04 mmol, 0.2 eq.), PhI(OAc)2 (0.6 mmol, 3.0 eq.), and Li3PO4 (0.4 mmol, 2.0 eq.) in DCE (2.0 mL) at 90 °C for 24 h.